Federico Nichetti, Medical Oncologist at Veneto Institute of Oncology, shared a post on X about a recent article he and his colleagues co-authored, adding:
“NEOPAN sparked intense brainstorming within our team at Scientific Institute for Research, Hospitalization and Healthcare.
We felt issues regarding OS, toxicity and age warranted a deeper dive.
That debate led to this Journal of Clinical Oncology letter. Hope PDAC colleagues find it thought-provoking! ”
Title: Chemotherapy for Locally Advanced Pancreatic Cancer: The Dilemma of David Versus Goliath After NEOPAN
Authors: Federico Nichetti, Letizia Procaccio, Sara Lonardi, Francesca Bergamo
Read the Full Article on Journal of Clinical Oncology
More posts about Pancreatic Cancer